Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation

BACKGROUND: Amiodarone is a frequently used antiarrhythmic drug in patients with end-stage heart failure. Given its long half-life, pre-transplant use of amiodarone has been controversially discussed, with divergent results regarding morbidity and mortality after heart transplantation (HTX). AIM: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivinius, Rasmus, Helmschrott, Matthias, Ruhparwar, Arjang, Schmack, Bastian, Erbel, Christian, Gleissner, Christian A, Akhavanpoor, Mohammadreza, Frankenstein, Lutz, Darche, Fabrice F, Schweizer, Patrick A, Thomas, Dierk, Ehlermann, Philipp, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762580/
https://www.ncbi.nlm.nih.gov/pubmed/26937171
http://dx.doi.org/10.2147/DDDT.S96126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762580/
https://www.ncbi.nlm.nih.gov/pubmed/26937171
http://dx.doi.org/10.2147/DDDT.S96126

Ejemplares similares